GIUSTI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.704
AS - Asia 5.296
EU - Europa 3.913
AF - Africa 1.371
SA - Sud America 1.121
OC - Oceania 165
Continente sconosciuto - Info sul continente non disponibili 77
Totale 27.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.909
SG - Singapore 1.735
CN - Cina 1.007
HK - Hong Kong 734
BR - Brasile 676
IT - Italia 637
FI - Finlandia 406
DE - Germania 355
VN - Vietnam 351
UA - Ucraina 226
SE - Svezia 218
FR - Francia 207
PL - Polonia 198
RU - Federazione Russa 177
GB - Regno Unito 161
IE - Irlanda 151
TR - Turchia 125
IN - India 108
NL - Olanda 95
AR - Argentina 76
MX - Messico 65
ES - Italia 62
IQ - Iraq 61
BJ - Benin 60
AZ - Azerbaigian 58
DO - Repubblica Dominicana 55
MD - Moldavia 55
AT - Austria 54
CA - Canada 54
ZA - Sudafrica 54
BE - Belgio 52
ID - Indonesia 52
JM - Giamaica 52
JP - Giappone 51
AU - Australia 50
EC - Ecuador 50
KE - Kenya 50
PA - Panama 50
VE - Venezuela 49
RS - Serbia 47
AL - Albania 45
AO - Angola 45
BO - Bolivia 45
CZ - Repubblica Ceca 45
LA - Repubblica Popolare Democratica del Laos 45
MG - Madagascar 45
GT - Guatemala 44
LB - Libano 44
MA - Marocco 44
PH - Filippine 44
SK - Slovacchia (Repubblica Slovacca) 44
SN - Senegal 44
CY - Cipro 43
NI - Nicaragua 43
UZ - Uzbekistan 43
PR - Porto Rico 42
PY - Paraguay 42
RO - Romania 42
UY - Uruguay 42
AE - Emirati Arabi Uniti 41
CO - Colombia 41
CR - Costa Rica 41
KR - Corea 41
BZ - Belize 40
KG - Kirghizistan 40
PT - Portogallo 40
TH - Thailandia 40
TN - Tunisia 40
CH - Svizzera 39
CI - Costa d'Avorio 39
CW - ???statistics.table.value.countryCode.CW??? 39
IR - Iran 39
IS - Islanda 39
NP - Nepal 39
TT - Trinidad e Tobago 39
YT - Mayotte 39
BA - Bosnia-Erzegovina 38
CM - Camerun 38
GE - Georgia 38
HN - Honduras 38
HU - Ungheria 38
KZ - Kazakistan 38
LV - Lettonia 38
MK - Macedonia 38
ZW - Zimbabwe 38
JO - Giordania 37
MZ - Mozambico 37
PK - Pakistan 37
BY - Bielorussia 36
EG - Egitto 36
MY - Malesia 36
PE - Perù 36
SA - Arabia Saudita 36
SI - Slovenia 36
BW - Botswana 35
CG - Congo 35
EE - Estonia 35
MU - Mauritius 35
XK - ???statistics.table.value.countryCode.XK??? 35
AD - Andorra 34
Totale 26.018
Salva come PNG Salva come JPEG
Città #
Fairfield 2.034
Woodbridge 1.619
Ann Arbor 1.211
Houston 1.172
Ashburn 1.167
Singapore 1.050
Chandler 927
Jacksonville 819
Wilmington 772
Seattle 734
Hong Kong 699
Cambridge 681
Boardman 345
Princeton 345
Beijing 238
Dong Ket 226
San Diego 202
Santa Clara 197
Medford 180
Des Moines 168
Padova 149
Nanjing 143
Bytom 136
Helsinki 130
Los Angeles 121
Munich 85
Guangzhou 73
New York 63
Roxbury 58
Baku 55
Cotonou 55
Dublin 54
São Paulo 52
Ho Chi Minh City 50
Chicago 48
Panama City 47
Dakar 44
Antananarivo 43
Milan 43
Rome 43
Shenyang 43
Vientiane 43
Hebei 42
Jiaxing 41
London 40
Managua 40
Nairobi 40
Chisinau 39
Turku 39
Tashkent 37
Warsaw 37
Abidjan 36
Harare 36
Nanchang 36
Bishkek 35
Buffalo 35
Luanda 35
Amman 34
Montevideo 34
Kingston 32
Riga 32
Ulan Bator 32
Washington 32
Andorra la Vella 31
Dushanbe 31
Libreville 31
Vienna 31
Havana 30
Jinan 30
Noumea 30
Tallinn 30
Willemstad 30
Castries 29
Istanbul 29
Kampala 29
Nassau 29
Podgorica 29
Yerevan 29
Bamako 28
Belgrade 28
Brooklyn 28
Conakry 28
Norwalk 28
Phnom Penh 28
San José 28
Tbilisi 28
Gaborone 27
Maputo 27
Reykjavik 27
Minsk 26
Bridgetown 25
Johannesburg 25
Lusaka 25
Mamoudzou 25
Nouakchott 25
Ouagadougou 25
Accra 24
Guatemala City 24
Hefei 24
Lilongwe 24
Totale 18.153
Salva come PNG Salva come JPEG
Nome #
Overview of the pharmacological properties and therapeutic efficacy of phospholipid liposomes (Liposom Forte®) in patients with depressive disorders 341
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. 316
Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry. 256
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway 256
Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. 224
Co-ultramicronized palmitoylethanolamide/luteolin promotes the maturation of oligodendrocyte precursor cells 220
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes 217
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism 216
Curcumin Prevents Acute Neuroinflammation and Long-Term Memory Impairment Induced by Systemic Lipopolysaccharide in Mice 210
Mast cells, glia and neuroinflammation: partners in crime? 208
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? 198
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron 198
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution 197
Co-Ultramicronized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte Precursor Cell Differentiation is Associated With Tyro3 Receptor Upregulation 193
Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations 190
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons 186
Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells 180
A proteomic approach in the study of an animal model of Parkinson's disease 178
A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis 178
Bisdemethoxycurcumin and Its Cyclized Pyrazole Analogue Differentially Disrupt Lipopolysaccharide Signalling in Human Monocyte-Derived Macrophages 177
Systematic review of pharmacological properties of the oligodendrocyte lineage 175
Current and emerging avenues for Alzheimer's disease drug targets 174
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia 173
Intracellular glutathione levels determine cerebellar granule neuron sensitivity to excitotoxic injury by kainic acid 169
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis 169
Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder 169
Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors 166
Neuroepigenetics and Alzheimer's Disease: An Update 166
Impairment of optokinetic nystagmus and optokinetic after-nystagmus in animals treated with 3-acetylpyridine 165
The Difficulty of Diabetic Therapy: an Observational Retrospective Study from Actual Clinical Practice 163
Synaptic Plasticity, Dementia and Alzheimer Disease 163
Serum amyloid A primes microglia for ATP-dependent interleukin-1β release 161
A new place conditioning paradigm to study tolerance to opiates in mice. 160
Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region 158
The P2X7 purinergic receptor: from physiology to neurological disorders 158
Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives 156
Active induction of experimental autoimmune encephalomyelitis in C57BL/6 mice 155
Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum 154
A model of systemic inflammation to study neuroinflammation 154
Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. 153
Acetylcholinesterase inhibition by tacrine analogues 152
Consumption of opioid analgesics in Italy: light at the end of the tunnel? 152
Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: A 5-year literature update and critical review 152
Effect of acute and chronic tramadol on [3H]-norepinephrine-uptake in rat cortical synaptosomes. 151
A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment 151
Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. 150
Toll-Like Receptors 2, -3 and -4 Prime Microglia but not Astrocytes Across Central Nervous System Regions for ATP-Dependent Interleukin-1β Release 150
Pre- and Early Post-treatment With Arthrospira platensis (Spirulina) Extract Impedes Lipopolysaccharide-triggered Neuroinflammation in Microglia 150
Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. 148
A 6-hydroxydopamine in vivo model of Parkinson's disease. 148
INFLUENCE OF GLYCINE ON MORPHINE-INDUCED ANTINOCICEPTION IN MICE 147
Cyclovinylogues of guanethidine. 146
Acetylcholinesterase Inhibitors: Synthesis and Structure-Activity Relationships of omega-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)-methyl]aminoalkoxyheteroaryl Derivatives. 145
Antidepressant drug prescribing patterns to outpatients of an italian local health authority during the years 1998 to 2008. 145
A sample research of hospitalized acute intoxication cases using an epidemiological form. 145
Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype. 144
Activated carbon as an external antidote: bringing it up to date 144
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. 141
Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A 141
Microglia and mast cells: two tracks on the road to neuroinflammation. 138
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity 137
Basic derivatives of 5-benzoyl-10,11-dihydro-5H-dibenz[b,f]azepine. 136
Benefit of statins in daily practice? A six-year retrospective observational study 136
Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal in mice. 135
Some cases of acute intoxications from compulsive use of isoaminile 135
Development of small-diameter vascular prostheses which release bioactive agents. 135
Resource consumption and costs of treating pain in patients affected by cancer in a district of northeast Italy. 134
Conditioned place preference: no tolerance to the rewarding properties of morphine. 134
The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4 134
Further evidences for neuroprotective effects of melatonin. 133
Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. 133
ANTINOCICEPTIVE ACTION OF GLYCINAMIDE 132
Abecarnil enhances recovery from diazepam tolerance. 132
Real-practice thromboprophylaxis in atrial fibrillation 132
Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate in rats. 131
Opioids in Italy: is marketing more powerful than the law? 131
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 131
Analgesic properties of N-terminal substituted phenylalanyl-alanine. 131
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 129
Glycine antinociceptive effects in mice 129
Antinociceptive effect of some carboxypeptidase A inhibitors in comparison with D-phenylalanine. 128
Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-methyl -D-Aspartate excitotoxicity 127
Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease 127
SSRI treatment induces a neurogenic response in rat cerebellar granule cells 126
Cerebellar granular cell cultures as an in vitro model for antidepressant drug-induced neurogenesis 125
Antioxydant and cytoprotective activioty og indole derivatives related to melatonin 125
Cost-of-illness della patologia diabetica in Italia: focus sul paziente con diabete di tipo 2 124
Proteomic study of 6-OHDA-induced neurodegeneration of rat nigrostriatal pathway 120
Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats. 120
An experimental study on dependence liability of zipeprol. 120
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003 119
Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abuse-dependent antagonism (RADA). 118
Isoniazid-induced inhibition of GABAergic transmission enhances the efficacy of imidazenil, a new partial agonist of benzodiazepine receptors 118
Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats. 118
The first application of Mössbauer spectroscopy in pharmacokinetics. I. Iron distribution in the rat 116
Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. 115
Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey 115
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities. 114
Synthetic enkephalins. Addicting properties and conformational studies in solution. 114
'Non-narcotic' analgesia in the mouse by transcutaneous electrical stimulation 114
Totale 15.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.448
article - articoli 70.816
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 1.790
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.158
Totale 159.212
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.689 0 0 0 0 81 193 70 204 344 183 285 329
2021/20222.696 60 427 315 185 93 85 125 317 131 42 355 561
2022/20232.093 457 194 26 215 372 292 4 116 249 33 87 48
2023/20241.203 50 119 178 102 71 185 43 78 46 72 123 136
2024/20254.157 31 148 178 194 603 171 237 254 397 143 726 1.075
2025/20267.218 545 1.437 2.402 2.798 36 0 0 0 0 0 0 0
Totale 27.740